Envista Holdings Corporation (NYSE:NVST) Receives $27.75 Average Price Target from Brokerages

Envista Holdings Corporation (NYSE:NVST) has earned a consensus recommendation of “Moderate Buy” from the fifteen research firms that are currently covering the company, MarketBeat.com reports. Seven investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $27.75.

Several analysts have recently issued reports on the company. William Blair upgraded Envista from a “hold” rating to an “outperform” rating in a research note on Friday, February 6th. Stifel Nicolaus set a $31.00 target price on Envista in a report on Friday, February 6th. JPMorgan Chase & Co. upped their target price on Envista from $22.00 to $26.00 and gave the stock a “neutral” rating in a research report on Friday, February 6th. Mizuho increased their price target on Envista from $24.00 to $27.00 and gave the company a “neutral” rating in a report on Tuesday, February 10th. Finally, Wells Fargo & Company lifted their price target on shares of Envista from $21.00 to $26.00 and gave the company an “equal weight” rating in a research report on Friday, February 6th.

Envista Stock Up 0.0%

Envista stock opened at $24.60 on Wednesday. The company has a current ratio of 2.38, a quick ratio of 2.04 and a debt-to-equity ratio of 0.47. Envista has a 1-year low of $14.22 and a 1-year high of $30.42. The firm’s fifty day simple moving average is $26.56 and its 200-day simple moving average is $22.92. The company has a market capitalization of $4.03 billion, a P/E ratio of 87.86, a P/E/G ratio of 1.68 and a beta of 0.95.

Envista (NYSE:NVST) last posted its earnings results on Thursday, February 5th. The company reported $0.38 EPS for the quarter, topping the consensus estimate of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. During the same quarter in the prior year, the business earned $0.24 EPS. Envista’s revenue for the quarter was up 15.0% on a year-over-year basis. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Sell-side analysts forecast that Envista will post 1 earnings per share for the current fiscal year.

Insider Transactions at Envista

In related news, SVP Mischa Reis sold 9,675 shares of Envista stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total value of $290,250.00. Following the transaction, the senior vice president owned 32,382 shares in the company, valued at $971,460. This trade represents a 23.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.66% of the company’s stock.

Institutional Investors Weigh In On Envista

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Parallel Advisors LLC boosted its stake in Envista by 13.1% during the 4th quarter. Parallel Advisors LLC now owns 3,175 shares of the company’s stock valued at $69,000 after purchasing an additional 367 shares during the period. Bank of Montreal Can grew its holdings in Envista by 1.4% in the 4th quarter. Bank of Montreal Can now owns 26,178 shares of the company’s stock valued at $568,000 after buying an additional 372 shares during the last quarter. Sepio Capital LP increased its position in Envista by 1.2% in the 4th quarter. Sepio Capital LP now owns 31,632 shares of the company’s stock worth $687,000 after buying an additional 374 shares during the period. Deutsche Bank AG lifted its holdings in shares of Envista by 2.9% during the fourth quarter. Deutsche Bank AG now owns 17,412 shares of the company’s stock worth $378,000 after buying an additional 484 shares during the last quarter. Finally, UMB Bank n.a. lifted its holdings in shares of Envista by 46.1% during the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock worth $44,000 after buying an additional 636 shares during the last quarter.

About Envista

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.